Intended for healthcare professionals

News

Covid-19: PPE guidance is upgraded as evidence of airborne transmission grows

BMJ 2021; 373 doi: https://doi.org/10.1136/bmj.n1422 (Published 02 June 2021) Cite this as: BMJ 2021;373:n1422
  1. Ingrid Torjesen
  1. London

More NHS staff caring for patients with suspected or confirmed covid-19 will have access to higher grade personal protective equipment (PPE), including FFP3 masks, under updated NHS guidance on covid-19 infection prevention and control.1

Issued this week, the updated guidance obliges NHS organisations to assess the risk that covid-19 poses to staff and to act to mitigate any risks, such as by providing higher grade PPE including FFP3 masks. These risk assessments should include evaluations of ventilation, operational capacity, and the prevalence of infections including new variants of concern in the local area.

The guidance also provides updates on the use of valved respirators and upper gastrointestinal endoscopy, advising that extended use of gowns must be minimised, with sessional use taking place only in areas where all patients have confirmed covid-19.

The BMA, which has led calls for better PPE throughout the pandemic,2 described the updated guidance as “a step in the right direction.”

The association’s council chair, Chaand Nagpaul, said, “Crucially, it recommends that respiratory PPE, such as FFP3 masks, must be considered where the threat from passing on covid remains high, and should not be limited to those areas where ‘aerosol generating procedures’ are taking place.

“This means extending their use to those staff whose exposure to airborne particles from a patient is no less, and whose risk of contracting covid is therefore no less than for those engaged in those procedures classified as [aerosol generating].”

He added, “Despite the majority of staff now having been vaccinated with two doses, it is important that those working on the front line should be given stronger guarantees with appropriate PPE, rather than just surgical masks, given that no vaccine provides complete protection.”

Risk assessments

The guidance update follows a review by the Scientific Advisory Group for Emergencies (Sage) published in April, which found that while respiratory diseases were “conventionally classed as either airborne or droplet in a clinical context,” current evidence suggested that SARS-CoV-2 fell between these two categories with transmission “possible through inhalation and mucous membrane exposure to a range of particle sizes, as well as potentially through fomites.”3

Sage said that the decision to use FFP3 respirators should be based on a risk assessment that considers the interaction with a patient, the duration and proximity of exposure, whether there is good fitting and mask adherence, whether staff are routinely wearing eye protection, and whether patients wear masks.

However, Pat Cullen, the Royal College of Nursing’s acting general secretary and chief executive, said that the guidance “focuses too much on aerosol generating procedures as the main risk and falls short of the precautionary approach we have been advocating,” adding that it left many workers in adult social care insufficiently protected.

“Those working in community settings, care homes, and many other areas are being let down and remain unsure how best to protect themselves,” said Cullen. “As we see new variants of concern emerge, we continue to demand that FFP3 masks are made more widely available and increased levels of ventilation as a standardised approach. This is in line with the advice from the World Health Organization and the Centers for Disease Control and Prevention on the risk of aerosol transmission.”

The updated guidance applies to NHS and independent hospitals, GP surgeries, mental health and learning disability settings, and care homes, but it does not apply to adult social care settings in England.

This article is made freely available for use in accordance with BMJ's website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.

https://bmj.com/coronavirus/usage

References

View Abstract